Tag: Exablate
Insightec launches next-generation Exablate Prime neurosurgery platform in Europe
Insightec has announced the CE-mark approval and European launch of Exablate Prime, which the company describes as a “significant enhancement” to its Exablate Neuro...
Insightec gains US FDA nod for five-year endpoint in MR-guided focused...
Insightec has announced US Food and Drug Administration (FDA) approval of the five-year study endpoint for what it claims is the largest prospective, long-term...
Insightec announces sustained and significant tremor improvement with focused ultrasound thalamotomy
Insightec has announced the publication of what it claims is the largest prospective, long-term follow-up study to date of unilateral magnetic resonance imaging-guided focused...
Indian health ministry approves Exablate Neuro focused ultrasound platform
Insightec has announced its incisionless neurosurgery platform, the Exablate 4000, has received market approval by the Central Drugs Standard Control Organization (CDSCO)—part of the Ministry...
Insightec announces Seoul National University Hospital is installing its Exablate Neuro...
Insightec has announced that Seoul National University Hospital (SNUH) is installing the company’s Exablate Neuro (Exablate 4000) platform—which uses focused ultrasound to ablate targets...
The Japanese Ministry of Health, Labour and Welfare approves Exablate Neuro...
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved InSightec’s Exablate Neuro system for the non-invasive treatment of essential tremor in patients...
